Anthrax disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
The disease is caused by either a homozygous or compound heterozygous mutation of the anthrax toxin receptor 2 (ANTXR2) gene.
|
30152846 |
2018 |
Anthrax disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
Capillary morphogenesis protein 2 (CMG2) was originally identified through its participation in capillary morphogenesis, and subsequently identified as the second receptor for anthrax toxin (ANTXR2).
|
29473166 |
2018 |
Anthrax disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
The protein-protein interaction between the human CMG2 receptor and the Bacillus anthracis protective antigen (PA) is essential for the transport of anthrax lethal and edema toxins into human cells.
|
28596569 |
2017 |
Anthrax disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
Stability of domain 4 of the anthrax toxin protective antigen and the effect of the VWA domain of CMG2 on stability.
|
27874231 |
2017 |
Anthrax disease
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
These findings further our understanding of human variability in ANTXR2 expression and anthrax toxin susceptibility.
|
26703731 |
2015 |
Anthrax disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
A recent genome-wide association study or GWAS identified that anthrax roxin receptor 2 (ANTXR2) was one of the risk loci for ankylosing spondylitis (AS).
|
25736362 |
2015 |
Anthrax disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
Silencing CMG2 using targeted siRNAs provided almost complete protection against anthrax lethal toxin-induced cytotoxicity and death in murine and human macrophages.
|
24742682 |
2014 |
Anthrax disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
The anthrax toxin receptor 2 (ANTXR2) is a type I membrane protein acting as the second receptor for the anthrax toxin.
|
24924630 |
2014 |
Anthrax disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
Capillary morphogenesis gene 2 (CMG2) is a receptor of anthrax toxin and plays an important role in angiogenesis.
|
24993339 |
2014 |
Anthrax disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
To explore whether proteins other than TEM8 and CMG2 function as anthrax toxin receptors in vivo, we challenged mice lacking TEM8 and/or CMG2.
|
23271637 |
2012 |
Anthrax disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
We will here review what is known about the structure of CMG2 and its ability to mediate anthrax toxin entry into cell.
|
22215446 |
2012 |
Anthrax disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
Treatment with CMG2-Fc did not interfere with the development of the animals' own immunity to anthrax, as treated animals that survived an initial challenge also survived a rechallenge 30 days later.
|
20956592 |
2011 |
Anthrax disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
The anthrax toxin receptors tumor endothelial marker-8 (TEM-8) and capillary morphogenesis gene-2 (CMG-2) are responsible for allowing entry of anthrax toxin into host cells.
|
21196249 |
2011 |
Anthrax disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
The Capillary Morphogenesis Gene 2 (CMG2) gene encodes an Anthrax toxin receptor (ANTXR2), but the normal physiological function is not known.
|
19901963 |
2010 |
Anthrax disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
In this study, we describe the identification and characterization of two murine monoclonal immunoglobulin G1 antibodies (MAbs), 1-F1 and 2-B12, which recognize distinct linear neutralizing epitopes on domain 4 of PA. 1-F1 recognized a 12-mer peptide corresponding to residues 692 to 703; this epitope maps to a region of domain 4 known to interact with the anthrax toxin receptor CMG-2 and within a conformation-dependent epitope recognized by the well-characterized neutralizing MAb 14B7.
|
19703971 |
2009 |
Anthrax disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
Moreover, we observed efficient PA-mediated uptake into anthrax toxin receptor (ANTXR)-deficient Chinese hamster ovary cells (PR230) that had been stably engineered to express either human ANTXR1 or human ANTXR2 in the presence or absence of siRNA specific for LRP5 or LRP6.
|
17335347 |
2007 |
Anthrax disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
Bacillus anthracis protective antigen (PA), the B subunit of the binary anthrax toxin, binds to the cellular receptors capillary morphogenesis gene 2 protein and tumor endothelial marker 8 with high affinity.
|
17942931 |
2007 |
Anthrax disease
|
0.300 |
Biomarker
|
disease |
RGD |
Moreover, a D683K mutant form of PA that bound specifically to human and rat ANTXR2 mediated killing of rats by anthrax lethal toxin, providing strong evidence for the physiological importance of ANTXR2 in anthrax disease pathogenesis.
|
17054395 |
2006 |